Home English Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA Share on Facebook Share on LinkedIn Share on Twitter Copy this URL Share via Email Join Fight CRC in a webinar about biomarkers. In this session, Dr. Chris Lieu will focus the discussion on the NTRK biomarker, in addition to ctDNA, and Next-Generation Sequencing. Watch the Webinar View the Slides Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA from Fight Colorectal Cancer Meet the Presenter Dr. Lieu joined the University of Colorado School of Medicine faculty in July 2011. He trained in internal medicine at the University of Colorado, where he also served as a Chief Medical Resident. He completed his fellowship training in medical oncology at the University of Texas MD Anderson Cancer Center and served as the Chief Medical Oncology Fellow in 2010. He currently serves as the Director of GI Medical Oncology at the University of Colorado Cancer Center, the Vice-Chair of the National Cancer Institute Colon Cancer Task Force, and he serves on the National Comprehensive Cancer Network (NCCN) Panel for Neuroendocrine Cancers. Research Dr. Lieu is a member of the Developmental Therapeutics (phase I clinical trials) and Gastrointestinal (GI) Medical Oncology Program. These comprehensive programs include multidisciplinary cancer clinics, tumor boards, and research endeavors. Dr. Lieu is interested in resistance mechanisms to targeted therapy in GI cancers, and he was awarded the Conquer Cancer Foundation Career Development Award and a NIH K23 grant to study targeted therapies in colorectal cancer. Dr. Lieu is also investigating novel therapeutic strategies to more effectively treat and prevent colorectal cancer in young adults. Sponsored by: